ABT-263

HOW IT IS BUILT The methods behind it Cellular senescence Senolytic WHAT IT CAN DO Its core abilities — — — — WHERE IT IS USED — · — — · — ABT-263 learns · reasons · acts
How it's built
What it can do
Where it's used

ABT-263, also known as navitoclax, is an experimental cancer drug that belongs to a class of medications called BCL-2 inhibitors. It works by blocking proteins that help cancer cells survive and evade death, essentially forcing tumors to self-destruct.